Trademark: 88468906
Word
VECTIVBIO
Status
Registered
Status Code
700
Status Date
Tuesday, March 9, 2021
Serial Number
88468906
Registration Number
6285701
Registration Date
Tuesday, March 9, 2021
Mark Type
4000
Filing Date
Tuesday, June 11, 2019
Published for Opposition
Tuesday, December 22, 2020

Trademark Owner History
VECTIVBIO AG - Original Registrant
Dikean Management AG - Original Applicant

Classifications
5 Nutritional additives for medical purposes in the nature of natural food extracts derived from herbs, fruits, spices, vegetables, algae, fungi; nutritional food additives for medical purposes in the nature of natural food extracts derived from meat, fish, poultry and game, meat extracts, fruit and canned vegetables, dried and cooked, jellies, jams, compotes, eggs, milk and milk products, edible oils and fats; phytopharmaceuticals for the treatment of autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; plant extracts for medical purposes; pharmaceutical for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; sanitary preparations for medical use; dietetic food, namely, herbs, fruits, spices, vegetables, algae, fungi; dietetic food, namely, food for babies; adjuvants for medical purposes; amino acids for medical purposes; anaesthetics; analgesics; vermifuges; antibiotics; biological preparations for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; chemical active components for medical use, namely, chemical preparations for treating genetic conditions, rare diseases and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; ferments for pharmaceutical purposes; hormones for medical purposes; medical infusions for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; medicines for the treatment of gum disease, caries, toothache and wound healing of the gums; medicines for the treatment of human diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; radiological contrast substances for medical purposes; steroids
1 Plant extracts for medical and pharmaceutical research purposes
44 Consulting on medicines, namely, medical and pharmaceutical consultation
10 Medical diagnostic apparatus for detecting diseases, disorders and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; Surgical apparatus and instruments for medical or veterinary use; Surgical and medical apparatus and instruments for use in orthopedic surgery; Medical and surgical apparatus and instruments, namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; Medical and surgical apparatus, medical instruments for use in treating genetic conditions, rare diseases and conditions, namely, autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; orthopaedic articles, namely, orthopedic devices for diagnostic and therapeutic use; orthopaedic articles, namely, vertebral orthopedic apparatus; suture materials; therapeutic and assistive devices adapted for the disabled, namely, motion sensing apparatus and assisted machines for the rehabilitation of hands and wrists, feet and ankles, knees, spine affected by neuromuscular diseases, disorders, or injuries for home or clinical use; massage apparatus; Medical and surgical apparatus and instruments, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery
42 Scientific research, technological development of new products for others; medical research; scientific and industrial research in the fields of biotechnology, biology, rare diseases and conditions, genetic conditions and treatments of rare diseases and conditions; industrial research in the field of biomedical and phytopharmaceutical engineering; pharmaceutical laboratory services; pharmaceutical research and development; scientific services, namely, development of drugs, active agents and vaccines; scientific services, namely, development of food supplements; development of pharmaceutical preparations and medicines; development of pharmaceuticals and medicines and plant extracts for use in pharmaceutical preparations and medicines

Trademark Events
Nov 7, 2023
Teas Change Of Correspondence Received
Nov 7, 2023
Teas Change Of Domestic Representatives Address
Nov 7, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 7, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 7, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 7, 2023
Teas Change Of Owner Address Received
Mar 9, 2021
Registered-Principal Register
Dec 22, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 22, 2020
Published For Opposition
Dec 2, 2020
Notification Of Notice Of Publication E-Mailed
Nov 12, 2020
Electronic Record Review Complete
Nov 6, 2020
On Hold - Electronic Record Review Required
Nov 5, 2020
Approved For Pub - Principal Register
Oct 28, 2020
Automatic Update Of Assignment Of Ownership
Oct 28, 2020
Teas/Email Correspondence Entered
Oct 27, 2020
Correspondence Received In Law Office
Oct 27, 2020
Teas Response To Office Action Received
Aug 13, 2020
Notification Of Non-Final Action E-Mailed
Aug 13, 2020
Non-Final Action E-Mailed
Aug 13, 2020
Non-Final Action Written
Jul 24, 2020
Teas/Email Correspondence Entered
Jul 24, 2020
Correspondence Received In Law Office
Jul 16, 2020
Teas Response To Suspension Inquiry Received
Mar 23, 2020
Notification Of Letter Of Suspension E-Mailed
Mar 23, 2020
Letter Of Suspension E-Mailed
Mar 23, 2020
Suspension Letter Written
Mar 10, 2020
Teas/Email Correspondence Entered
Mar 9, 2020
Correspondence Received In Law Office
Mar 9, 2020
Teas Response To Office Action Received
Sep 10, 2019
Notification Of Non-Final Action E-Mailed
Sep 10, 2019
Non-Final Action E-Mailed
Sep 10, 2019
Non-Final Action Written
Sep 3, 2019
Assigned To Examiner
Jul 1, 2019
Teas/Email Correspondence Entered
Jul 1, 2019
Correspondence Received In Law Office
Jun 25, 2019
Assigned To Lie
Jun 24, 2019
New Application Office Supplied Data Entered
Jun 19, 2019
Teas Voluntary Amendment Received
Jun 14, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24